According to Illumina's latest financial reports the company's current revenue (TTM) is $4.50 B. In 2022 the company made a revenue of $4.58 B an increase over the years 2021 revenue that were of $4.52 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $4.50 B | -1.72% |
2022 | $4.58 B | 1.26% |
2021 | $4.52 B | 39.73% |
2020 | $3.23 B | -8.58% |
2019 | $3.54 B | 6.33% |
2018 | $3.33 B | 21.12% |
2017 | $2.75 B | 14.7% |
2016 | $2.39 B | 8.05% |
2015 | $2.21 B | 19.25% |
2014 | $1.86 B | 30.97% |
2013 | $1.42 B | 23.74% |
2012 | $1.14 B | 8.81% |
2011 | $1.05 B | 16.93% |
2010 | $0.90 B | 35.48% |
2009 | $0.66 B | 16.24% |
2008 | $0.57 B | 56.28% |
2007 | $0.36 B | 98.71% |
2006 | $0.18 B | 151.13% |
2005 | $73.5 M | 45.3% |
2004 | $50.58 M | 80.43% |
2003 | $28.03 M | 179.23% |
2002 | $10.04 M | 303.76% |
2001 | $2.48 M |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
Thermo Fisher Scientific TMO | $42.85 B | 851.53% | ๐บ๐ธ USA |
Agilent Technologies A | $6.73 B | 49.53% | ๐บ๐ธ USA |
Quest Diagnostics
DGX | $9.25 B | 105.42% | ๐บ๐ธ USA |
Danaher DHR | $23.89 B | 430.42% | ๐บ๐ธ USA |
PerkinElmer
PKI | $3.35 B | -25.46% | ๐บ๐ธ USA |
Translate Bio
TBIO.defunct | $0.22 B | -95.00% | ๐บ๐ธ USA |
Pacific Biosciences
PACB | $0.20 B | -95.55% | ๐บ๐ธ USA |
Luminex LMNX | N/A | N/A | ๐บ๐ธ USA |